263 related articles for article (PubMed ID: 29610985)
21. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
Fan B; Cen S; Jiang JD
Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
[TBL] [Abstract][Full Text] [Related]
22. Host APOBEC3G protein inhibits HCV replication through direct binding at NS3.
Zhu YP; Peng ZG; Wu ZY; Li JR; Huang MH; Si SY; Jiang JD
PLoS One; 2015; 10(3):e0121608. PubMed ID: 25811715
[TBL] [Abstract][Full Text] [Related]
23. Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins.
Huthoff H; Malim MH
Virology; 2005 Apr; 334(2):147-53. PubMed ID: 15780864
[TBL] [Abstract][Full Text] [Related]
24. Reduction of N-tropic mutant porcine endogenous retrovirus infectivity by human tripartite motif-containing 5-isoform alpha.
Lee J; Cho YD; Heo YK; Kwon Y; Kim DG; Choi BS; Kim SS; Kim YB
Transplant Proc; 2011 Sep; 43(7):2774-8. PubMed ID: 21911161
[TBL] [Abstract][Full Text] [Related]
25. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
Bishop KN; Holmes RK; Malim MH
J Virol; 2006 Sep; 80(17):8450-8. PubMed ID: 16912295
[TBL] [Abstract][Full Text] [Related]
26. Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid-binding protein.
Chaurasiya KR; McCauley MJ; Wang W; Qualley DF; Wu T; Kitamura S; Geertsema H; Chan DS; Hertz A; Iwatani Y; Levin JG; Musier-Forsyth K; Rouzina I; Williams MC
Nat Chem; 2014 Jan; 6(1):28-33. PubMed ID: 24345943
[TBL] [Abstract][Full Text] [Related]
27. APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon.
Armitage AE; Deforche K; Chang CH; Wee E; Kramer B; Welch JJ; Gerstoft J; Fugger L; McMichael A; Rambaut A; Iversen AK
PLoS Genet; 2012; 8(3):e1002550. PubMed ID: 22457633
[TBL] [Abstract][Full Text] [Related]
28. Hypermutation of an ancient human retrovirus by APOBEC3G.
Lee YN; Malim MH; Bieniasz PD
J Virol; 2008 Sep; 82(17):8762-70. PubMed ID: 18562521
[TBL] [Abstract][Full Text] [Related]
29. [Recent advances in the study of mechanism of APOBEC3G against virus].
Zhu YP; Jiang JD; Peng ZG
Yao Xue Xue Bao; 2014 Jan; 49(1):30-6. PubMed ID: 24783502
[TBL] [Abstract][Full Text] [Related]
30. Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination.
Gillick K; Pollpeter D; Phalora P; Kim EY; Wolinsky SM; Malim MH
J Virol; 2013 Feb; 87(3):1508-17. PubMed ID: 23152537
[TBL] [Abstract][Full Text] [Related]
31. Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent.
Browne EP; Allers C; Landau NR
Virology; 2009 May; 387(2):313-21. PubMed ID: 19304304
[TBL] [Abstract][Full Text] [Related]
32. Transmissible infection of human 293T cells with porcine endogenous retroviruses subgroup a from NIH-miniature pig.
Lee D; Kim NY; Bae GE; Lee HJ; Kwon M; Kim SS; Lee HT; Yang JM; Kim YB
Transplant Proc; 2008 Dec; 40(10):3742-5. PubMed ID: 19100479
[TBL] [Abstract][Full Text] [Related]
33. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.
Adolph MB; Ara A; Chelico L
J Mol Biol; 2019 Mar; 431(7):1339-1352. PubMed ID: 30797859
[TBL] [Abstract][Full Text] [Related]
34. Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding.
Bennett RP; Presnyak V; Wedekind JE; Smith HC
J Biol Chem; 2008 Mar; 283(12):7320-7. PubMed ID: 18165230
[TBL] [Abstract][Full Text] [Related]
35. Lack of evidence for PERV expression after apoptosis-mediated horizontal gene transfer between porcine and human cells.
Bisset LR; Böni J; Lutz H; Schüpbach J
Xenotransplantation; 2007 Jan; 14(1):13-24. PubMed ID: 17214701
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F.
Yang Y; Guo F; Cen S; Kleiman L
Virology; 2007 Aug; 365(1):92-100. PubMed ID: 17459442
[TBL] [Abstract][Full Text] [Related]
37. Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1.
Jaguva Vasudevan AA; Hofmann H; Willbold D; Häussinger D; Koenig BW; Münk C
J Mol Biol; 2017 Apr; 429(8):1171-1191. PubMed ID: 28315663
[TBL] [Abstract][Full Text] [Related]
38. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.
Zhang H; Yang B; Pomerantz RJ; Zhang C; Arunachalam SC; Gao L
Nature; 2003 Jul; 424(6944):94-8. PubMed ID: 12808465
[TBL] [Abstract][Full Text] [Related]
39. APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.
Nowarski R; Prabhu P; Kenig E; Smith Y; Britan-Rosich E; Kotler M
J Mol Biol; 2014 Jul; 426(15):2840-53. PubMed ID: 24859335
[TBL] [Abstract][Full Text] [Related]
40. Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase.
Nowarski R; Britan-Rosich E; Shiloach T; Kotler M
Nat Struct Mol Biol; 2008 Oct; 15(10):1059-66. PubMed ID: 18820687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]